Latest News and Press Releases

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Perjeta (Pertuzumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...

Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2022: By Product, By Indication, By Distribution" report has been added to ResearchAndMarkets.com's...

Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Breast Cancer Drug Market (2021-2026) by Drug Type, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with...

Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...

Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "HER2 Targeting Therapies Market by Target Disease Indication, Type of Molecule, Type of Therapy and Route of Administration, Key Geographical Regions:...

Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "HER2+ Breast Cancer - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. Breast cancer is...

Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Trastuzumab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Trastuzumab is a monoclonal...

Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Major...